Although there is indirect genetic evidence that MEN1, the gene for multiple endocrine neoplasia type 1, is a tumor suppressor gene, little is known about the MEN1-encoded protein, menin. Menin was stably overexpressed in a well-characterized murine tumor cell line, (valine-12)-RAS-transformed NIH3T3 cells. Menin overexpression reverted the morphology of the RAS-transformed NIH3T3 cells towards the more¯attened and more spread, ®broblastic shape of wild type NIH3T3 cells. The proliferation rate of the RAS-transformed cells in 0.5% calf serum was also slower with menin overexpression. Menin overexpression reduced the RASinduced clonogenicity in soft agar. Menin also reduced tumor growth after injection of cells in nude mice. In conclusion, stable overexpression of MEN1 suppressed partially the RAS-mediated tumor phenotype in vitro and in vivo. Overexpressed menin protein had biological eects, directly supporting MEN1 gene function as a tumor suppressor.
Introduction
Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder, caused by inactivating mutations in a presumed tumor suppressor gene, termed MEN1. In an aected individual, one germline inactive MEN1 allele is present in all cells, and a mono-or oligo-clonal tumor develops after the remaining wild type allele has been inactivated by somatic mutation (in one or several cells) (Larsson et al., 1988; Marx, 1998) . The MEN1 gene was localized to 11q13 (Larsson et al., 1988) and later identi®ed by positional cloning . Mutation analysis of the MEN1 gene has so far revealed more than 200 MEN1 index cases with unique heterozygous germ-line mutations Bassett et al., 1998; Teh et al., 1998; Giraud et al., 1998; Poncin et al., 1999; Mutch et al., 1999) . Analogous somatic mutations in the MEN1 gene are a major contributor to sporadic tumors: parathyroid adenomas, lung carcinoids, gastrinomas, insulinomas, and angio®bromas Debelenko et al., 1997; Zhuang et al., 1997; Boni et al., 1998) . Two-thirds of the germline or somatic MEN1 mutations predict a truncated and presumably inactive menin protein (Marx, 1998) . The high frequency of inactivating germline or somatic mutations and the coexistence of 11q13 LOH in tumors support indirectly the prediction that the MEN1 gene is a tumor suppressor gene (Larsson et al., 1988) .
Recently, the menin protein was shown to be located primarily in the nucleus (Guru et al., 1998) and to bind the transcription factor, junD (Agarwal et al., 1999) . In addition, junD-activated transcription is inhibited by menin expression. Even so, little is known about the function of menin in normal cells or in tumorigenesis.
RAS is an oncogene originally identi®ed in rat sarcoma virus (Satoh et al., 1992) . Transforming RAS genes cause tumor progression, often accompanied by somatic mutations in tumor suppressor genes (Vogelstein and Kinzler, 1993) . Transfection of the activated cellular RAS can transform murine NIH3T3 cells (Murray et al., 1981) . This model has been useful in analyses of oncogenes (Finlay et al., 1989) and tumor suppressor genes (Luo et al., 1995; Eliyahu et al., 1989) .
RAS-transformed NIH3T3 cells were used herein to explore MEN1 as a possible tumor suppressor. The stable overexpression of menin decreased the oncogenic eects of ras upon cell morphology, proliferation, and tumor growth.
Results

Menin protein is overexpressed in RAS-NIH3T3 cells, stably transfected with MEN1
Murine MSV-NIH3T3-RAS-(G12V) cells were transfected with a plasmid, containing the complete open reading frame of the human MEN1 transcript together with a hygromycin resistance gene, driven by the CMV promoter. There was no dierence in the eciency of transfection between empty pcDNA3.1.hyg vector and the MEN1 plasmid. Following double selection in medium containing hygromycin and G418, individual clones were screened for overexpression of menin by immunoblot and immuno¯uorescence analyses. Seven cell lines which overexpressed menin were established; four (RM1, RM2, RM3 and RM4) were selected for the highest menin expression. Quantitative immunoblots probed with SQV antibody showed that menin protein in the stable MEN1-transfected lines was from seven to 27 times that in the parental line ( Figure 1a ). Actin was tested as an index for equal loading of the total cell lysates in each lane. The experiments were repeated three times with similar results. Menin in RAS-MEN1-transfected cell lines (RM1 ± 4) was divided by menin in control RAS-transformed NIH3T3 cells (R); menin as these ratios (mean+s.d.) was RM1, 7+3; RM2, 13+9; RM3, 27+14; RM4, 15+2. After 6 months in continuous cell culture, the menin overexpression in RM1, RM2, RM3 and RM4 cell lines was unchanged. There was no dierence in menin levels between wild type and RAS-transformed NIH3T3 cell lines.
Although loss of oncogenic RAS and consequent loss of oncogenic phenotype during the isolation of the RAS-MEN1-transfected cells was unlikely, since these cells were under double antibiotic selection, the status of the transfected RAS was evaluated. The RAS-G12V transcript was found by sequencing RAS-transformed and RAS-MEN1-transfected RM4 lines, whereas the NIH3T3 cells showed only wild type murine RAS sequence (not shown). Ras protein was overexpressed in RAS-NIH3T3 cells, presumably as a mixture of normal and oncogenic ras. Ras protein was similarly overexpressed in RAS-MEN1-transfected cells (Figure 1b) . Nuclear localization of menin in RAS-NIH3T3 cells Similar to prior ®ndings in non oncogenic cells (Guru et al., 1998) , the endogenous menin in RAStransformed NIH3T3 cells was mainly in the nucleus (Figure 2 ). When the epitope of the AEA antibody was blocked with AEA peptide, the nuclear staining was abolished (Figure 2a, b) . In the MEN1-transfected RAS-NIH3T3 cells, immunostaining with AEA antibody con®rmed the overexpression of menin and showed augmented nuclear staining. This also was blocked by the AEA peptide (Figure 2c,d ).
Menin partially normalizes the transformed cell morphology caused by oncogenic Ras in RAS-NIH3T3 cells
The substitution with certain amino acids at codon 12 or 61 of RAS blocks the endogenous ras GTPase activity and results in a constitutively active ras oncoprotein (Solonas and Escrich, 1996) . Transfection of oncogenic, mutated RAS resulted in transformation of NIH3T3 cells (Satoh et al., 1992) . NIH3T3 cells, transfected with GI2V-RAS (glycine replaced by valine at position 12), were used herein. Compared to wild type NIH3T3 cells, the RAStransformed NIH3T3 cells were abnormally refractile and fusiform, with compact nuclei and disrupted micro®lament network. Cells expressing oncogenic ras and overexpressing menin showed more normal shape with more¯attened, spread, and polygonal morphology ( Figure 3 ). The size of the MEN1-transfected RAS-NIH3T3 cells was slightly larger than that of NIH3T3-WT cells (Figure 3 ). These cell shape changes were observed in all four RM cell lines (not shown). In addition, while RAStransformed cells rapidly detached from the surface of the culture dish on reaching con¯uence, the menin overexpressing RAS-NIH3T3 cells attached to the tissue culture plastic more ®rmly than did RAStransformed cells. This phenomenon has been reported in other RAS revertants (Luo et al., 1995; Pfarr et al., 1994) .
Menin overexpression in RAS-transformed NIH3T3 cells slows cell proliferation
Constitutively active ras allowed NIH3T3 cells to grow in low serum concentration. In low calf serum (0.5% CS), all four RM cell lines grew more slowly than R cells, more like the WT NIH3T3 cells (Figure 4 ). The slower cell growth of RM cells was also observed in complete DMEM media containing 10% CS (data not shown). Another observation after cell culture in 0.5% CS media was that, at a cell con¯uency of 50 ± 70%, RAStransformed cells formed many foci on the plate while the WT and RM cells did not form any foci ( Figure 5 ).
Menin suppresses the clonogenicity of Ras-transformed ®broblasts in soft agar
Cells were plated in soft agar to see the eect of menin on anchorage independent growth. The eciency of colony formation was signi®cantly (P50.05) less in all four menin-overexpressing cell lines than in the parental RAS-NIH3T3 cell line (Figure 6 ). In addition, colonies formed by RM cell lines were smaller, i.e. approximately one fourth in colony area, compared to colonies from the parental RAStransformed cell line (Table 1) .
Menin overexpression inhibits tumor growth in nude mice
The eect of menin on tumor growth was evaluated in vivo. Cells from the four RM lines along with cells from the R line were injected into athymic nude mice. Tumors from RM3 and RM4 cells showed a signi®cantly (P50.05) suppressed volume compared to tumors from R cells throughout the three consecutive days of analyses ( Figure 7 ). The tumor volume was reduced to one-third of that of R cells (P50.05) at day 17. Tumors from RM1 and RM2 cells showed a suppressive eect of menin at day 15 (P50.05); however, as tumor progressed further, the eect was not signi®cant (RM1, P=0.06 at day 17, RM2, P=0.53 at day 17). The tumors were removed and weighed at day 17. Tumors from RM1, RM3, and RM4 cell lines showed signi®cantly (P50.05) reduced tumor weight compared to tumors from R cell line (Figure 7) . Anti-tumor eects of menin overexpression in nude mice varied between four dierent RAS-MEN1-NIH3T3 cell lines. Further analyses would be needed to determine whether menin overexpression remains stable in all lines during growth in nude mice. Overall these results from nude mice show that menin overexpression partially suppressed in vivo the RASinduced tumor growth.
Discussion
A tumor suppressor gene can be assessed in neoplastic cells having null status of the same gene by transfecting that gene, and then testing for the normalization of neoplastic phenotype (Huang et al., 1988) . However, no MEN1 null cell line is currently available. An alternate tester cell line is a surrogate for such null cells ± that is, cells with a neoplastic phenotype, caused by a dierent gene or genes. Through this approach, tumor suppressor genes such as P53 (Finlay et al., 1989; Eliyahu et al., 1989) , RB1 (Zhou et al., 1994) , WT1 (Luo et al., 1995) , and PML (Mu et al., 1994) have been found to revert transformed null-surrogate cells fully or partially towards the non-transformed status. Since activated RAS oncogenes are frequently found in human cancers (Solonas and Escrich, 1996) , and, since the transforming eect of this gene provides convenient alterations of phenotype, menin eects were tested in RAS-transformed NIH3T3 cells. The median of R cell line was compared to that for other lines using the Wilcoxon rank sum test. NA=not applicable. NS=not signi®cant Ras is a cytoplasmic signal-transducer, which transmits extracellular information to the intracellular MAPK (mitogen-activated protein kinase) cascade. Ras stimulates cell proliferation in ®broblast cells in response to various growth factors including FGF (Kouhara et al., 1997) , EGF, PDGF, and insulin (Satoh et al., 1992) . When the receptor for FGF, EGF or PDGF is activated by autophosphorylation in response to growth factors, it recruits the ras protein to the plasma membrane, and the extracellular signals are transduced to the cytoplasmic Raf, MEK (MAP kinase kinase), and MAPK pathway, and then to transcription factors in the nucleus (Gutkind, 1998) .
All of the previously observed germline or somatic truncating mutations of MEN1 were predicted to be oncogenic and to remove one or both of menin's nuclear localization signals (Guru et al., 1998) . One potential oncogenic eect of ras could be blockade of nuclear localization of normal menin. However, there was a normal nuclear localization of both endogenous and overexpressed menin in a RAS-NIH3T3 background.
Menin's nuclear localization also implies that the anti-tumor and anti-proliferative eects of overexpressed menin in RAS-MEN1-NIH3T3 cells are initiated by menin in the nucleus. This could include secondary induction of changes in cytoplasm and other cell compartments.
The RAS-NIH3T3 cells stably transfected with MEN1 plasmid showed approximately 7 ± 27-fold the menin concentration of parental RAS-NIH3T3 cells. Menin-overexpressing RAS-NIH3T3 cell lines showed slower proliferation rate than their parental cell line, RAS-transformed NIH3T3 cells. The expression level of menin in the four RM cell lines was not proportionally related to the observed eects in MEN1-transfected RAS-NIH3T3 cells. A nonlinear relationship between the level of expression of the tumor suppressor gene, and a partial inhibition of tumor growth has also been reported for other transcription regulating tumor suppressor genes such as RB1 (Zhou et al., 1994) and WT1 (Luo et al., 1995; Haber et al., 1993) .
A partial normalization of the cell morphology was observed in all four RAS-MEN1-NIH3T3 cell lines. Ras-transformed cells can grow in soft agar independently of anchorage (Pfarr et al., 1994) . In our study, MEN1-transfected cells showed a reduced number of soft agar colonies, and the size of colonies was smaller than those of their RAS-NIH3T3 precursor cells. The above changes could re¯ect menin counteracting the oncogenic eects of ras.
There are no prior data about interaction of the ras pathways and menin pathways. Even the present data do not imply any close interaction of the pathways. The data herein do not distinguish between menin acting within the ras cogenic pathway, within a parallel pathway, or both. The most remote relationship would be that of two independent pathways ultimately in¯uencing one very distal event, such as cell cycling.
Overall, these analyses indicate that stable overexpression of menin has a growth and tumor suppressive eect in NIH3T3-RAS cells. This is the ®rst direct demonstration of this postulated MEN1 function (Larsson et al., 1988) . These cell lines may be useful to characterize further the cellular actions of menin.
Materials and methods
Preparation of stable cell lines
The open reading frame of the MEN1 transcript with its own Kozak consensus (GCCATG (Kozak et al., 1991) ) was ampli®ed by the polymerase chain reaction (PCR) using the MEN1 clone as a template. The ampli®ed fragment after restriction was ligated into the HindIII and NotI sites of pcDNA3.1.hyg (In Vitrogen, Carlsbad, CA, USA) and con®rmed by cycle sequencing (ABI Prism Dye Terminator, Perkin Elmer Applied Biosystems, Foster City, CA, USA). NIH3T3 cells, stably transformed with oncogenic murine MSV-RAS-(G12V) (from Dr J Silvio Gutkind, National Institute of Dental Research) (Crespo, 1994) were plated at a density of 2610 5 cells per 60 mm diameter culture dish in DMEM (Bio¯uids Inc, Rockville, MD, USA) plus 10% calf serum (Bio¯uids Inc. Rockville, MD, USA). MEN1 plasmid DNA (i.e. pcDNA 3.1 hyg.menin) was puri®ed twice in cesium chloride. After 24 h, the cells were transfected with 5 mg of puri®ed MEN1 plasmid DNA using Superfect (Qiagen, Santa Clarita, CA, USA). Two days after transfection, hygromycin and G418, 500 mg/ml and 750 mg/ ml respectively were added to culture media. Two weeks later, hygromycin and G418 resistant colonies were picked using glass cloning cylinders (Bellco Glass, Vine Land, NJ, USA), and colonies were expanded into stable cell lines. The stable cell lines were checked for menin expression by immunoblotting, and the four cell lines expressing the highest amounts of menin were selected and characterized further. A control transfection was done with pcDNA3.1.hyg plasmid.
Cell culture NIH3T3 cells were grown at 378C in 5% CO 2 in DMEM (Bio¯uids Inc, Rockville, MD, USA) supplemented with 10% calf serum (CS, Bio¯uids Inc, Rockville, MD, USA), 100 mg/ ml streptomycin and 100 units/ml penicillin, and 1 mM glutamine (complete DMEM media). For cell proliferation experiments with RAS-transformed NIH3T3 (R) and RAS-MEN1-stably transfected (RM) cells, the medium contained 0.5% CS. To maintain the R cells 750 mg/ml G418 was added to the complete DMEM media, while to maintain RM cells 500 mg/ml of hygromycin and 750 mg/ml G418 were added.
Antibodies and peptides
Rabbit polyclonal antibodies, AEA and SQV, were directed against the menin C-terminus peptides, AEAEEPWGEEAR-EGRRRGPRRESKPEEP and SQVQMKKQKVSTPSDYT-LSFLKRQRKGL respectively (Guru et al., 1998) . Rabbit polyclonal ras antibody (Santa Cruz Biotechnology Inc, Santa Cruz, CA, USA) was used to assess ras expression. Goat polyclonal actin antibody (Santa Cruz Biotechnology Inc, Santa Cruz, CA, USA) was used to check equal loading of the cell lysates. For the AEA peptide competition, peptide and antibody at a 20 : 1 ratio were preincubated at 48C overnight before use.
Cell extracts and immunoblot analysis
Cells were grown to 70% con¯uency on culture dishes and rinsed with Dulbecco's phosphate buered saline (DPBS) once. The cells were then harvested using a rubber cell scraper in DPBS with a cocktail of protease inhibitors, Complete TM (Boehringer Mannheim, Indianapolis, IN, USA), and centrifuged at 250 g for 5 min at 48C. The cell pellet was suspended in lysis buer (0.25 M Tris.HCl, pH 8.0) containing Complete TM and frozen in dry ice immediately for 30 min. The frozen cell pellet was then thawed in a 378C water bath for 30 s. The freeze and thaw cycle was repeated four times. Aliquots of the lysed total cell extracts were used for protein determination (Bradford, Bio-Rad, Hercules, CA, USA), and the remainder was mixed with 26SDS sample loading buer (100 mM Tris.HCl pH 6.8, 200 mM DTT, 4% SDS, 0.2% bromophenol blue, 20% glycerol) and boiled for 5 min to denature all proteins. Equal amounts of protein were separated on 10% SDS ± PAGE (NOVEX, San Diego, CA, USA) and transferred to a nitrocellulose membrane (0.45 mM pore size, S & S, Keene, NH, USA). The membrane was blocked with 10% milk in TBST (20 mM Tris.HCl, pH 7.5, 500 mM NaCl, 0.05% Tween 20) for 1 h. Primary antibodies, SQV menin antibody or ras antibody or actin antibody, were added to fresh blocking solution and incubated with the membrane for 1 h with shaking at room temperature. The blot was washed in TBST for 20 min, and washed two more times. The blot was incubated with goat anti-rabbit secondary antibody (Amersham Life Science, Arlington Heights, IL, USA) for menin (SQV), donkey anti-rabbit secondary antibody (Santa Cruz Biotechnology Inc, Santa Cruz, CA, USA) for RAS, and donkey anti-goat secondary antibody (Santa Cruz Biotechnology Inc, Santa Cruz, CA, USA) for actin, all secondary antibodies had been conjugated with horseradish peroxidase. The blot was analysed with enhanced chemiluminescence (Amersham Life Science, Arlington Heights, IL, USA). The protein images were analysed using Bio-Imaging Analyzer Bas-1500 (Fuji®lm, Japan) with Adope Photoshop and Soft Max softwares for scanning and quantitation respectively.
Sequencing of oncogenic RAS segment
Total RNA was isolated from NIH3T3 cells, RAStransformed NIH3T3 cells, and RAS-MEN1-transfected NIH3T3 cells using Trizol and reverse transcribed into ®rst strand cDNA using SuperScript II and random hexamers (Life Technologies, Inc). A DNA fragment containing most of the coding region of the RAS mRNA was synthesized from these cDNAs with Platinum Taq DNA polymerase and pRAS5 plus rpRAS1 (Life Technologies, Inc). DNA sequence was obtained from gel puri®ed bands in a reaction containing the labeled rpRAS5 primer (Promeg, Inc) and Taq polymerase (Perkin Elmer). Primers were as follows: GAG-CACACACTTGCAGCTCATGCAG-rpRAS1; GGAATAT-AAGCTGGTGGTGGTGGGC-pRAS5; CCCTCCCCGGT-GCGCATGTACTGGT-rpRAS5.
Imaging of cells
Cells to be immunostained were grown in 4-well chamber slides (Labtek, Nalge Nunc International, Naperville, IL, USA), rinsed in PBS, and ®xed in a cold 3.5% paraformaldehyde solution for 8 min. The ®xed cells were rinsed in PBS and then permeabilized for 5 min in TBS with 0.1% Triton X-100. The cells were blocked with goat serum for 30 min at 378C; they were then incubated with the AEA antibody (3 mg/ml) in PBS with 1% BSA and 0.2% Triton X-100, for 1 h at room temperature. The cells were rinsed three times in PBS with 0.2% Triton X-100. Cells were incubated with Texas-Red conjugated goat anti-rabbit IgG (1 : 100 dilution, Amersham Life Science, Arlington Heights, Illinois, USA) as a secondary antibody for 1 h at room temperature in the dark. Cells were rinsed four times in PBS with 0.2% Triton X-100 and mounted. Images were obtained using an Axiophot microscope (Zeiss, Germany) with 406 magni®cation. For a morphology study, cells were plated on a 60 mm round culture dish and grown for 2 days before photography with an Axiovert 405M microscope (Zeiss, Germany).
Soft agar assays
For the assay of cell growth in soft agar, 3 ml of 0.6% agar (Difco, Detroit, MI, USA), prepared in DMEM plus 10% CS, were poured into 60 mm culture dishes and solidi®ed. One hundred cells were mixed in 0.3% agar in complete medium and plated over solidi®ed 0.6% agar. The innoculated culture dishes were incubated for 14 days, and the colonies were scored under the microscope.
Tumorigenicity in nude mice
Cells in logarithmic growth phase were harvested, washed, and resuspended in 100 ml of PBS for injection. Five sets of ®ve male athymic nude mice were injected subcutaneously in the intrascapular region with 1610 6 cells per animal, using each of the R, RM1, RM2, RM3, and RM4 cell lines. As the mice developed visible tumor, the width, length, and height of the tumor were measured daily for three consecutive days. All nude mice were sacri®ced at day 17, and tumors were dissected and weighed.
Statistical analyses
Data are expressed and depicted as measn+standard deviation. The size of colonies formed in soft agar, the tumor volumes, and the tumor weights were analysed by Wilcoxon rank sum test (Hollander and Wolfe, 1973) . For the number of colonies produced in soft agar, the data from the individual plates were found to be consistent with a binomial distribution, and thus were analysed by logistic regression (Cox, 1970) . Abbreviations MEN1, multiple endocrine neoplasia type 1; MEN1, gene for MEN1; WT, wild type; R, RAS-NIH3T3 cells; RMX, RAS-and MEN1-transfected NIH3T3 cells, with`X' indicating cell line number(s); AEA and SQV, antisera against menin, named by codes for the ®rst three amino acids of the synthetic peptide used for immunization; G12V, normal glycine at amino acid 12, substituted by valine; EM, Menin (human sequence with poly-histidine added at N-terminus) expressed in E. coli.
